LIMERICK, Pa.--(BUSINESS WIRE)--Sep. 13, 2012--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, has announced it has received FDA
510(k) clearance to market its pressure injectable ARROW®
PICC preloaded with the ARROW® VPS® Vascular
Positioning System® Stylet. The ARROW VPS replaces the need
for confirmatory chest X-ray in the presence of a stable Blue Bullseye
by using state-of-the-art, real-time intravascular Doppler, ECG and
advanced algorithmic logic to notify the clinician that the catheter tip
has reached the optimal location. The preloaded option improves
clinician ease of use for vascular navigation and catheter tip
positioning.
“We are dedicated to providing technologies for clinicians who strive to
make zero complications in vascular care a reality,” said Paul Molloy,
President, Vascular Division of Teleflex. “Providing clinicians with the
ARROW VPS Stylet preloaded into the ARROW PICC is one of a series of new
product introductions that demonstrates our continuous commitment to
reducing vascular access complications and improving ease of use for
clinicians.”
From a workflow perspective, the preloaded ARROW PICC benefits
clinicians by saving the time and process of loading the ARROW VPS
Stylet into the catheter. Clinically, the ARROW VPS confirms accurate
catheter tip position in the lower 1/3 of the SVC-Cavo-Atrial Junction,
which has been proven to reduce complications such as thrombosis.1
The ARROW PICC features a TaperFree™ body designed to ensure
consistent French size along the entire length of the catheter.2, 3
In accordance with national recommended guidelines, the ARROW PICC
powered by ARROW VPS Stylet will be available in an
ergonomically-designed, sharps safety, maximal barrier kit that reduces
the risk of infection and accidental needle sticks at insertion.
Additional information may be found at www.arrowintl.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 11,200 people worldwide and serves
healthcare providers in more than 130 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, the Blue Bullseye symbol, TaperFree, Vascular
Positioning System and VPS are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates.
©2012 Teleflex
Incorporated. All rights reserved. 2012-1211.
|
|
|
References:
|
|
1.
|
|
|
Cadman, A., Lawrance, J., Fitzsimmons, L., Spencer-Shaw, A., &
Swindell, R. (2004). To clot or not to clot? That is the question
in central venous catheters. Clinical Radiology 59, 349–355.
|
|
2.
|
|
|
Trerotola, S, Stavropoulos, S, Mondschein, J, et al. Triple-lumen
peripherally inserted central catheter in patients in the critical
care unit: prospective evaluation. Radiology
2010;256(1):312-330.
|
|
3.
|
|
|
Nifong TP and McDevitt TJ. The effect of catheter to vein ratio on
blood flow rates in a simulated model of peripherally inserted
central venous catheters. Chest 2011;140;48-53.
|
|
|
|
|
|

Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836